Abstract
Although the importance of atropine in therapy of organophosphate (OP) poisoning is generally recognized, its dosing is a matter of debate. A retrospective analysis of atropine dosing was undertaken in 34 patients who had been enrolled in a clinical study assessing obidoxime effectiveness in OP-poisoning. All patients were severely intoxicated (suicidal attempts) and required artificial ventilation. Atropine was administered routinely by intensive care physicians for life-threatening muscarinic symptoms, with the recommendation to favor low dosage. The pharmacological active enantiomere S-hyoscyamine was determined by a radioreceptor assay.When RBC-AChE activity ranged between 10% and 30%, S-hyoscyamine plasma concentrations of approx. 5nmolL-1 were sufficient. This concentration could be maintained with about 0.005mgh-1kg-1 atropine. Only when RBC-AChE was completely inhibited, therapy of cholinergic crisis required atropine doses up to 0.06mgh-1kg-1. Elimination half-life of S-hyoscyamine was 1.5h, showing occasionally a second slow elimination phase with t1/2=12h. Malignant arrhythmias were observed in some 10% of our cases, which occurred late and often in the absence of relevant glandular cholinergic signs, when the S-hyoscyamine concentration was below 2.5nmolL-1. Arrhythmias mostly resolved on reinstitution of atropine.
| Original language | English |
|---|---|
| Pages (from-to) | 77-83 |
| Number of pages | 7 |
| Journal | Toxicology Letters |
| Volume | 206 |
| Issue number | 1 |
| DOIs | |
| State | Published - 25 Sep 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acetylcholinesterase
- Atropine
- Dysrhythmia
- Human
- Organophosphorus pesticide
- Pharmacokinetics
- Poisoning
Fingerprint
Dive into the research topics of 'Atropine maintenance dosage in patients with severe organophosphate pesticide poisoning'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver